Hi, I am Oludotun Adebayo Phillips, My LiveDNA is 1.1738
 
   
  Home
 
 
 
Dr. Oludotun Adebayo Phillips
 
Highest Degree: Ph.D. in Medicinal Chemistry from University of Saskatchewan, Canada
 
Institute: Kuwait University, Kuwait
 
Area of Interest: Pharmacology and Toxicology
  •   Medicinal Chemistry
  •   Pharmaceutical Analysis
  •   Drug Design
  •   Antimicrobial
 
URL: http://livedna.org/1.1738
 
My SELECTED Publications
1:   Abdel-Hamid, M.E. and O.A. Phillips, 2003. LC-MS/MS determination of Synercid® injections. J. Pharm. Biomed. Anal., 32: 1167-1174.
PubMed  |  
2:   Abdel-Hamid, M.E. and O.A. Phillips, 2003. LC-MS/MS determination of carbamazepine, pindolol and theophylline in human serum. J. Liq. Chromatogr. Related. Technol., 26: 1937-1957.
CrossRef  |  Direct Link  |  
3:   Al-Sweih, N., E. Mokaddas, W. Jamal, O.A. Phillips and V.O. Rotimi, 2005. In vitro activity of linezolid and other antibiotics against Gram-positive bacteria from the major teaching hospitals in Kuwait. J. Chemother., 17: 607-613.
PubMed  |  
4:   Edafiogho, E.E., O.A. Phillips, E.E. Udo, S. Samuel and B. Rethish, 2009. Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones. Eur. J. Med. Chem., 44: 967-975.
Direct Link  |  
5:   Novotny, L., O.A. Phillips, P. Rauko and E. Miadokova, 2006. Antileukemic activity of sulfanilamide conjugates of arabinosylcytosine. Exp. Oncol., 28: 293-298.
Direct Link  |  
6:   Phillips, O.A. and M.E. Abdel-Hamid, 2008. Determination of novel antibacterial triazolylmethyl oxazolidinones concentrations in human plasma by APCI-LC-MS: Application to stability study. J. Pharm. Pharmceut. Sci., 11: 22S-31S.
Direct Link  |  
7:   Phillips, O.A., A.V.N. Reddy, E.L. Setti, P. Spevak and D.P. Czajkowski et al., 2005. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases. Bioorg. Med. Chem., 13: 2847-2858.
PubMed  |  
8:   Phillips, O.A., E.E. Udo and S. Samuel, 2008. Synthesis and structure-antibacterial activity of triazolyl oxazolidinones containing long chain acyl moiety. Eur. J. Med. Chem., 43: 1095-1104.
PubMed  |  
9:   Phillips, O.A., E.E. Udo, A.A.M. Ali and S. Samuel, 2007. Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones. Eur. J. Med. Chem., 42: 214-225.
PubMed  |  
10:   Phillips, O.A., E.E. Udo, M.E. Abdel-Hamid and R. Varghese, 2009. Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazolyl)methyl oxazolidinones. Eur. J. Med. Chem., 44: 3217-3227.
CrossRef  |  Direct Link  |  
11:   Phillips, O.A., K.T. Mathew and M.A. Oriowo, 2006. Antihypertensive and vasodilator effects of methanolic and aqueous extracts of Tribulus terrestris in rats. J. Ethnopharmacol., 104: 351-355.
CrossRef  |  Direct Link  |  
12:   Phillips, O.A., L.H. Sharaf, M.E. Abdel-Hamid and R. Varghese, 2011. Assessment of the stability of novel antibacterial triazolyl-oxazolidinones using a stability-indicating high performance liquid chromatography method. Med. Princ. Pract., 20: 51-59.
PubMed  |  
13:   Phillips, O.A., V.O. Rotimi, W.Y. Jamal, M. Shahin and T.L. Verghese, 2003. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria. J. Chemother, 15: 113-117.
PubMed  |  
14:   Pinter, G., I. Bereczki, E. Roth, A. Sipos and R. Varghese et al., 2011. The effect of systematic structural modifications on the antibacterial activity of novel oxazolidinones. Med. Chem., 7: 45-55.
PubMed  |